These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 17923114

  • 1. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C, Sköld MK, Li J, Nennesmo I, Fadeel B, Henter JI.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):989-93. PubMed ID: 17923114
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
    Rizvanov AA, Kiyasov AP, Gaziziov IM, Yilmaz TS, Kaligin MS, Andreeva DI, Shafigullina AK, Guseva DS, Kiselev SL, Matin K, Palotás A, Islamov RR.
    Neurochem Int; 2008 Dec 30; 53(6-8):389-94. PubMed ID: 18948156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K.
    Rinsho Shinkeigaku; 2007 Nov 30; 47(11):934-7. PubMed ID: 18210840
    [Abstract] [Full Text] [Related]

  • 10. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
    Lambrechts D, Storkebaum E, Carmeliet P.
    Trends Mol Med; 2004 Jun 30; 10(6):275-82. PubMed ID: 15177192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J.
    Curr Opin Investig Drugs; 2006 Jan 30; 7(1):54-9. PubMed ID: 16425672
    [Abstract] [Full Text] [Related]

  • 14. VEGF and ALS.
    Sathasivam S.
    Neurosci Res; 2008 Oct 30; 62(2):71-7. PubMed ID: 18656504
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
    Ohta Y, Kamiya T, Nagai M, Nagata T, Morimoto N, Miyazaki K, Murakami T, Kurata T, Takehisa Y, Ikeda Y, Asoh S, Ohta S, Abe K.
    J Neurosci Res; 2008 Oct 30; 86(13):3028-37. PubMed ID: 18543336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.
    Gowing G, Lalancette-Hébert M, Audet JN, Dequen F, Julien JP.
    Exp Neurol; 2009 Dec 30; 220(2):267-75. PubMed ID: 19733170
    [Abstract] [Full Text] [Related]

  • 20. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
    Funakoshi H, Ohya W, Kadoyama K, Nakamura T.
    Brain Nerve; 2007 Oct 30; 59(10):1195-202. PubMed ID: 17969361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.